Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn?

Author:

Martino Simona Di1,Petri Giovanna Li1,De Rosa Maria1ORCID

Affiliation:

1. Drug Discovery Unit, Medicinal Chemistry Group, Ri.MED Foundation, Palermo 90133, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Reference189 articles.

1. Viral hepatitis update: Progress and perspectives

2. World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021-Data Slides. World Health Organization, 2021. https://cdn.who.int/media/docs/default-source/hq-hiv-hepatitis-and-stis-library/who_ghss_global_report_2021_ppt.pdf?sfvrsn=386417bb_20 (accessed 2023–09–18).

3. World Health Organization. Global hepatitis report, 2017. https://www.who.int/publications/i/item/9789241565455 (accessed 2023–09–18).

4. Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation

5. Istituto Superiore di Sanità. Bollettino SEIEVA epidemiologia delle epatiti virali acute in Italia. Istituto Superiore di Sanità, 2020. https://www.epicentro.iss.it/epatite/bollettino/Bollettino-n-6-marzo-2020.pdf (accessed 2023-09–18).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3